Plain English Summary
Background and study aims
Immediately after birth, a baby's heart rate (HR) is measured to determine if babies need help with their breathing. This was traditionally done using a stethoscope. Over the last ten years, pulse oximeters have increasingly been used to measure HR after birth. Pulse oximeters (PO) are machines which non-invasively measure blood oxygen levels and HR. PO measures HR by counting the number of pulses in the hand. They have been used to monitor infants HR for many years. More recently, electrocardiograms (ECG) have been recommended to measure HR in newly born infants. This method uses sensors to measure HR. For either method, it is important that information is displayed quickly, especially right after birth when it is critical to know if a baby requires help breathing. The National Maternity Hospital (Ireland) current uses PO to measure and monitor HR of a baby right after birth. However, the hospital has machines that combine both ECG and PO that are being used in the neonatal unit (post birth unit). These could be used instead of PO to measure HR right after birth if they are able to quickly measure and monitor HR of babies. The aim of this study is to compare two different heart monitoring machines to see how quickly they are able to provide HR information.
Who can participate?
Babies born at the National Maternity Hospital (Ireland)
What does the study involve?
Newborn babies are randomly allocated to one of two groups. Those in the first group have their HR measured using a monitor that combines both an ECG and a PO. This involves an ECG sensor and a PO monitored placed around their right wrist or hand. Those in the second group have their HR measured only using a PO monitor that is placed around their right wrist or hand. The time taken for each monitor to display the babies HR is recorded and there is no further follow up involved for participants.
What are the possible benefits and risks of participating?
There are no notable benefits or risks with participating.
Where is the study run from?
National Maternity Hospital (Ireland)
When is the study starting and how long is it expected to run for?
February 2017 to June 2017
Who is funding the study?
National Maternity Hospital (Ireland)
Who is the main contact?
Professor Colm O’Donnell
Trial website
Contact information
Type
Scientific
Primary contact
Prof Colm O'Donnell
ORCID ID
http://orcid.org/0000-0001-7453-5452
Contact details
Neonatal Unit
National Maternity Hospital
Holles Street
Dublin
D02 YH21
Ireland
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
SHEEP001
Study information
Scientific title
A randomised study of heart rate estimation comparing two monitors (electrocardiogram plus pulse oximeter versus pulse oximeter alone) in newly-born infants
Acronym
SHEEP
Study hypothesis
Electrocardiogram and pulse oximetry gives a heart rate (HR) more quickly than pulse oximetry alone in the first minutes of life.
Ethics approval
Research Ethic Committee at the National Maternity Hospital, 06/03/2017, ref: EC04.2017
Study design
Single-centre unmasked randomised parallel group study
Primary study design
Observational
Secondary study design
Randomised parallel group comparison
Trial setting
Hospitals
Trial type
Other
Patient information sheet
Not available in web format, please use the contact details below to request a patient information sheet
Condition
Delivery room care of newborn infants
Intervention
Newly-born infants are transferred to an open resuscitation cot as practicable after birth. Infants are randomly allocated to one of two groups.
Intervention group: Infants are monitored using the Intellivue X2 monitor (Philips, Eindhoven, Netherlands) which incorporates electrocardiogram (ECG) and pulse oximetry (PO). The infants have the ECG applied before the PO sensor is placed around their right wrist or hand and attached to the machine.
Control group: Infants are monitored with a Nellcor PM1ON portable PO (Covidien, Boulder CO, USA). The PO sensor is placed around the right wrist or hand and then attached to the machine. Infants are observed to ensure that they are well as is standard with any birth.
The time taken for each monitor to display the infants heart rate (HR) is recorded and the infants participation in the study ends at this point and there is no further follow-up. The duration of participation is around five minutes.
Intervention type
Other
Phase
Drug names
Primary outcome measure
Time to first heart rate from monitor application measured in seconds using a stopwatch.
Secondary outcome measures
1. Failure of monitoring (i.e. heart is not displayed) is measured within 5 minutes of applying the monitor
2. Time taken to apply monitor is measured in seconds using a stopwatch
3. Skin damage with leads/sensors are measured by visual inspection at around five minutes
Overall trial start date
01/02/2017
Overall trial end date
30/06/2017
Reason abandoned (if study stopped)
Eligibility
Participant inclusion criteria
All infants (term and pre-term) born at National Maternity Hospital.
Participant type
Patient
Age group
Neonate
Gender
Both
Target number of participants
100
Participant exclusion criteria
1. Major congenital anomalies
2. No antenatal consent
Recruitment start date
17/04/2017
Recruitment end date
15/06/2017
Locations
Countries of recruitment
Ireland
Trial participating centre
National Maternity Hospital
Neonatal Unit
Holles Street
Dublin
D02 YH21
Ireland
Funders
Funder type
Hospital/treatment centre
Funder name
National Maternity Hospital
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Submission of results for presentation at the annual meeting of the European Society for Paediatric Research and Pediatric Academic Societies.
IPD sharing plan:
The current data sharing plans for the current study are unknown and will be made available at a later date
Intention to publish date
30/06/2018
Participant level data
To be made available at a later date
Basic results (scientific)
Publication list